Planning Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Planning Strategies's VRTX Position: Q3 2026 in Review
Planning Strategies increased its Vertex Pharmaceuticals (VRTX) stake by 4.4% in Q3 2026, buying an estimated $1.02K and bringing the position to 47 shares worth $24.6K. The position accounts for 0.01% of the portfolio, ranked #230.
Planning Strategies first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,653 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Planning Strategies held 47 shares of Vertex Pharmaceuticals worth $24.6K as of Q3 2026.
- Planning Strategies bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
- Vertex Pharmaceuticals made up 0.01% of Planning Strategies's portfolio in Q3 2026, its #230 holding.
- Planning Strategies first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 1,653 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.